跳至主要内容
临床试验/NL-OMON31888
NL-OMON31888撤回3 期

The effectiveness of intensive treatment on sympathetic hyperactivity. A randomized, cross-over trial in patients with chronic kidney disease and hypertension - The effect of intensive treatment on sympathetic hyperactivity

Academisch Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
撤回
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with stable chronic kidney disease and hypertension: i.e. using antihypertensive drugs and/or blood pressure >145/90mmHg when off medication.

排除标准

  • Patients with diabetes mellitus and patients on renal replacement therapy are excluded. In addition, patients with severe liver insufficiency, biliary cirrhosis and cholestasis, use of calcium antagonists en beta-blockers, pregnant patients and patients in lactation are excluded as Valsartan is contra-indicated for these patients.

研究者

相似试验